Rayno Life Science DX and Tools Update: EXAS

source link Exact Sciences (EXAS) is down about 8% to $10.65 on heavy volume after a Wedbush Downgrade to Neutral. Preliminary data coming next week. The stock was added to the Rayno Life Sciences Portfolio on 12/10/10.Barron’s had a positive article on Oct 6 and the Company raised $58M in August with a follow-on offering. The stock is up 3.8% over 30 days and 31.3% YTD.

Lyrica cheap price Diagnostics and Tools stocks are mainly in the red today. Cepheid (CPHD) down 1.6% today is approaching an entry strategic long term buy near $32 with a market cap of $2.2B. 2012 Revenues are forecasted in the $340M range.

No comments yet.

Leave a Reply